Company: SMNR
Filing Date: 2025-03-27
Form Type: DEF 14A
Source: 0001013762-25-003461
Chunk: 66

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-03-27
Form: DEF 14A
Chunk 66
---
 requirements of Rule 14a -8of the Exchange Act and the Articles in place at such time. Shareholder and Interested Party Communications Shareholders and interested parties may communicate with the Board, any committee chairperson or the non -managementdirectors as a group by writing to the Board or committee chairperson in care of Denali Capital Acquisition Corp., 437 Madison Avenue, 27 thFloor, New York, NY 10022. HOUSEHOLDING INFORMATION Unless we have received contrary instructions, we may send a single copy of this proxy statement to any household at which two or more shareholders reside if we believe the shareholders are members of the same family. This process, known as “householding,” reduces the volume of duplicate information received at any one household and helps to reduce our expenses. However, if shareholders prefer to receive multiple sets of our disclosure documents at the same address this year or in future years, the shareholders should follow the instructions described below. Similarly, if an address is shared with another shareholder and together both of the shareholders would like to receive only a single set of our disclosure documents, the shareholders should follow these instructions: •If the shares are registered in the name of the shareholder, the shareholder should contact us at (646) 978 -5180to inform us of his or her request; or •If a bank, broker or other nominee holds the shares, the shareholder should contact the bank, broker or other nominee directly. 42 WHERE YOU CAN FIND MORE INFORMATION We file reports, proxy statements and other information with the SEC as required by the Exchange Act. You can read the Company’s SEC filings, including this proxy statement, over the Internet at the SEC’s website at www.sec.gov. If you would like additional copies of this proxy statement or if you have questions about the proposals to be presented at the extraordinary general meeting, you should contact the Company’s proxy solicitation agent at the following address, telephone number and email: Advantage Proxy, Inc.
P.O. Box 10904
Yakima, WA 98909
Toll -Free: (877) 870 -8565
Collect: (206) 870 -8565
Email: ksmith@advantageproxy.com You may also obtain these documents by requesting them from the Company at: Denali Capital Acquisition Corp.
437 Madison Avenue, 27 thFloor
New York, New York 10022
(646) 978 -5180 If you are a shareholder of the Company and would like to request documents, please do so